Synthesis and SAR of novel GPR39 agonists and positive allosteric modulators

被引:2
|
作者
Burley, Russell [1 ]
Hewer, Richard C. [1 ]
Teall, Martin [1 ]
Dickson, Louise [1 ]
Ossola, Bernardino [1 ]
Russell, Sam [1 ]
Bender, Clare [1 ]
Cheung, Toni [1 ]
Powell, Justin A. C. [1 ]
Xu, Xiao [1 ]
Brice, Nicola [1 ]
Otter, Lucy [1 ]
Arimont, Marta L. [2 ]
Kidd, Sarah [2 ]
Vidal, David [2 ]
Dale, James W. [2 ]
Mervin, Lewis [2 ]
Sore, Hannah F. [2 ]
Mateu, Natalia [2 ]
Lakshminarayana, Narayana [3 ]
Dawson, Lee A. [1 ]
Carlton, Mark [1 ]
Buerli, Roland W. [1 ]
机构
[1] Cerevance Ltd, 418 Cambridge Sci Pk,Milton Rd, Cambridge, Cambs, England
[2] PharmEnable Ltd, 2 Hazlewell Court,Bar Rd, Cambridge, Cambs, England
[3] Aragen Life Sci Ltd, Plot 284A Part,Bommasandra Jigani Link Rd Ind A, Bengaluru 562106, India
关键词
GPR39; G protein-coupled receptor; Agonist; Parkinson 's disease; RECEPTOR; DISCOVERY;
D O I
10.1016/j.bmcl.2022.128607
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report a significant decrease in transcription of the G protein-coupled receptor GPR39 in striatal neurons of Parkinson's disease patients compared to healthy controls, suggesting that a positive modulator of GPR39 may beneficially impact neuroprotection. To test this notion, we developed various structurally diverse tool molecules. While we elaborated on previously reported starting points, we also performed an in silico screen which led to completely novel pharmacophores. In vitro studies indicated that GPR39 agonism does not have a profound effect on neuroprotection.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc
    Sato, Seiji
    Huang, Xi-Ping
    Kroeze, Wesley K.
    Roth, Bryan L.
    MOLECULAR PHARMACOLOGY, 2016, 90 (06) : 726 - 737
  • [2] GI functions of GPR39: novel biology
    Depoortere, Inge
    CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (06) : 647 - 652
  • [3] The pathophysiological functions and therapeutic potential of GPR39: Focus on agonists and antagonists
    Cheng, Yuhui
    Zhao, Chang
    Bin, Yan
    Liu, Yuan
    Cheng, Lin
    Xia, Fan
    Tian, Xiaowen
    Liu, Xinlei
    Liu, Sicen
    Ying, Binwu
    Shao, Zhenhua
    Yan, Wei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [4] Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists
    Peukert, Stefan
    Hughes, Richard
    Nunez, Jill
    He, Guo
    Yan, Zhao
    Jain, Rishi
    Llamas, Luis
    Luchansky, Sarah
    Carlson, Adam
    Liang, Guiqing
    Kunjathoor, Vidya
    Pietropaolo, Mike
    Shapiro, Jeffrey
    Castellana, Anja
    Wu, Xiaoping
    Bose, Avirup
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (10): : 1114 - 1118
  • [5] Identification of novel GPR39 agonists that stimulate insulin and GLP-1 secretion in vitro using StaR® technology
    Mace, O. J.
    Andrews, S.
    Brown, A. J. H.
    Brown, S.
    Congreve, M.
    Jazayeri, A.
    Patel, J.
    Prihandoko, R.
    Tehan, B.
    Marshall, F.
    DIABETOLOGIA, 2013, 56 : S264 - S265
  • [6] Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents
    Fjellstrom, Ola
    Larsson, Niklas
    Yasuda, Shin-ichiro
    Tsuchida, Takuma
    Oguma, Takahiro
    Marley, Anna
    Wennberg-Huldt, Charlotte
    Hovdal, Daniel
    Fukuda, Hajime
    Yoneyama, Yukimi
    Sasaki, Kazuyo
    Johansson, Anders
    Lundqvist, Sara
    Brengdahl, Johan
    Isaacs, Richard J.
    Brown, Daniel
    Geschwindner, Stefan
    Benthem, Lambertus
    Priest, Claire
    Turnbull, Andrew
    PLOS ONE, 2015, 10 (12):
  • [7] Synthesis and SAR of piperazinyl and homopiperazinyl analogs as positive allosteric modulators of mGluR4
    Cheung, Yiu-Yin
    Hopkins, Corey R.
    Niswender, Colleen
    Lindsley, Craig W.
    Conn, P. Jeffrey
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [8] Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia
    Fell, Matthew J.
    McKinzie, David L.
    Monn, James A.
    Svensson, Kjell A.
    NEUROPHARMACOLOGY, 2012, 62 (03) : 1473 - 1483
  • [9] Novel positive allosteric modulators of GABAA receptors
    Sigel, E
    Dodd, RH
    DRUGS OF THE FUTURE, 2001, 26 (12) : 1191 - 1197
  • [10] Novel AMPA receptor allosteric modulators of bis(pyrimidine) series: synthesis and SAR evaluation
    Sedenkova, Kseniya N.
    Kositov, Sergey V.
    Zverev, Denis V.
    Radchenko, Eugene V.
    Grishin, Yuri K.
    Gabrel'yan, Alexey V.
    Zamoyski, Vladimir L.
    Grigoriev, Vladimir V.
    Averina, Elena B.
    Palyulin, Vladimir A.
    MENDELEEV COMMUNICATIONS, 2024, 34 (01) : 8 - 10